Immediate Impact
1 from Science/Nature 11 hit
Citing Papers
Neurotoxic Soluble Amyloid Oligomers Drive Alzheimer’s Pathogenesis and Represent a Clinically Validated Target for Slowing Disease Progression
2021 Hit
Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval
2020 Hit
Works of Diane Lacombe being referenced
Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis
2006